173 related articles for article (PubMed ID: 16423825)
1. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy.
Shojania S; O'Neil JD
J Biol Chem; 2006 Mar; 281(13):8347-56. PubMed ID: 16423825
[TBL] [Abstract][Full Text] [Related]
2. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP
Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
[TBL] [Abstract][Full Text] [Related]
3. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.
Péloponèse JM; Grégoire C; Opi S; Esquieu D; Sturgis J; Lebrun E; Meurs E; Collette Y; Olive D; Aubertin AM; Witvrow M; Pannecouque C; De Clercq E; Bailly C; Lebreton J; Loret EP
C R Acad Sci III; 2000 Oct; 323(10):883-94. PubMed ID: 11098404
[TBL] [Abstract][Full Text] [Related]
4. The Dynamic Landscape of the Full-Length HIV-1 Transactivator of Transcription.
To V; Dzananovic E; McKenna SA; O'Neil J
Biochemistry; 2016 Mar; 55(9):1314-25. PubMed ID: 26866386
[TBL] [Abstract][Full Text] [Related]
5. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
[TBL] [Abstract][Full Text] [Related]
6. Conformation of N-terminal HIV-1 Tat (fragment 1-9) peptide by NMR and MD simulations.
Kanyalkar M; Srivastava S; Coutinho E
J Pept Sci; 2001 Nov; 7(11):579-87. PubMed ID: 11763362
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic disorder and function of the HIV-1 Tat protein.
Shojania S; O'Neil JD
Protein Pept Lett; 2010 Aug; 17(8):999-1011. PubMed ID: 20450479
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
Long KS; Crothers DM
Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
[TBL] [Abstract][Full Text] [Related]
9. Complete 1H nuclear magnetic resonance assignments and structural characterization of a fusion protein of the alpha-amylase inhibitor tendamistat with the activation domain of the human immunodeficiency virus type 1 Tat protein.
Freund J; Vértesy L; Koller KP; Wolber V; Heintz D; Kalbitzer HR
J Mol Biol; 1995 Jul; 250(5):672-88. PubMed ID: 7623384
[TBL] [Abstract][Full Text] [Related]
10. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
Ziegler A; Blatter XL; Seelig A; Seelig J
Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
[TBL] [Abstract][Full Text] [Related]
11. High yield expression and purification of HIV-1 Tat1-72 for structural studies.
Shojania S; Henry GD; Chen VC; Vo TN; Perreault H; O'Neil JD
J Virol Methods; 2010 Mar; 164(1-2):35-42. PubMed ID: 19941902
[TBL] [Abstract][Full Text] [Related]
12. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation.
Terreux R; Pairot S; Cabrol-Bass D; Patino N; Condom R
J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.
Wrenger S; Hoffmann T; Faust J; Mrestani-Klaus C; Brandt W; Neubert K; Kraft M; Olek S; Frank R; Ansorge S; Reinhold D
J Biol Chem; 1997 Nov; 272(48):30283-8. PubMed ID: 9374514
[TBL] [Abstract][Full Text] [Related]
14. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.
Mujeeb A; Bishop K; Peterlin BM; Turck C; Parslow TG; James TL
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8248-52. PubMed ID: 8058789
[TBL] [Abstract][Full Text] [Related]
15. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
17. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic investigations of HIV-1 trans-activator and related peptides in aqueous solutions.
Klostermeier D; Bayer P; Kraft M; Frank RW; Rösch P
Biophys Chem; 1997 Jan; 63(2-3):87-96. PubMed ID: 9108685
[TBL] [Abstract][Full Text] [Related]
19. Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.
Pantano S; Marcello A; Ferrari A; Gaudiosi D; Sabò A; Pellegrini V; Beltram F; Giacca M; Carloni P
Proteins; 2006 Mar; 62(4):1062-73. PubMed ID: 16362936
[TBL] [Abstract][Full Text] [Related]
20. Structure of RNA aptamer complexed with an RNA-binding peptide of Tat with aid of residue-specific 13C, 15N labeling.
Matsugami A; Tochio H; Niyada E; Tamura Y; Kudo M; Misono TS; Kumar P; Katahira M
Nucleic Acids Symp Ser (Oxf); 2005; (49):69-70. PubMed ID: 17150637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
